User Fee Talks On Schedule And Making Progress, Industry Says
10.03.11
Publication: The Gray Sheet By:
Despite FDA warnings that time is running out for an agreement to be reached with industry on a user fee reauthorization plan, device industry leaders say the two sides have made “good progress” toward reaching a pact.
“We are in concert with them,” Jim Mazzo, senior VP of Abbott Medical Optics and chair of AdvaMed’s board, said during a press event at the trade association’s annual meeting in Washington, D.C., Sept. 26.






